Logo Image
|Articles|September 20, 2011

BalanceSense, LLC Awards StudyManager Phase II Study for Returning Troops with Mild-Trauma Brain Injury

StudyManager

announced that

BalanceSense, LLC

awarded StudyManager an eight-site, Phase II Army contract to implement Evolve CTMS and EDC.
 
BalanceSense sought a flexible, easy to use solution for the management of clinical data captured by physical therapists treating returning troops with mild-trauma brain injuries, and to centralize, track, and manage study progress.
 
“We are pleased to have the opportunity to contribute to this important effort in working with Dr. Karen Atkins, PhD, PT, Balance Sense, LLC and her team,” said Sue Blecman, Vice President of Sales, StudyManager. “It’s a privilege for StudyManager and Evolve to have been selected as one of BalanceSense’s civilian partners to support much needed treatment for our returning troops. We look forward to their clinical and operational success with this study.”

Evolve's web-based interface integrates clinical trial management and electronic data capture tools. These features are very scalable, and can be used together seamlessly or independently. Evolve enables users to create a single, centralized and secure location for key study information, simplifying study operations and enhancing team efficiency.

Related to this article

View more
© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
What "Patient Voice" Actually Requires: Beyond the Buzzword
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
Read more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more